Circular Dichroism (CD) Spectrometers Market Analysis

Circular Dichroism Spectrometers Market Analysis

To get key market trends

  Download Free Sample

Based on product, the market is segmented into linearly polarized light sources, circularly polarized light sources, and multiple light sources. The circularly polarized light sources segment is anticipated to reach USD 32.7 million by 2032.
 

• As research in fields such as biochemistry, biophysics, pharmaceuticals, and materials science continue to advance, there is a growing need for sophisticated analytical techniques. Circular dichroism (CD) spectroscopy, which relies on circularly polarized light sources, is a powerful tool for studying the structure and interactions of chiral molecules. The increasing complexity of research questions in these areas drives the segment expansion.
   
• Additionally, circularly polarized light sources are used for characterizing materials with chiral properties, such as crystals, polymers, and nanoparticles. Understanding the chiral behavior of materials is crucial for various industries including pharmaceuticals, cosmetics, and nanotechnology, anticipated to derive the increased demand for circularly polarized light sources.  
   

Based on type, the CD spectrometers market is segmented into benchtop and portable. The benchtop segment is anticipated to reach USD 58.6 million by 2032.
 

• Benchtop CD spectrometers are often more versatile in terms of wavelength range, sensitivity, and experimental capabilities. They may offer a wider range of measurement modes and accessories, allowing for more complex experiments and sample analyses making them more prominently used by researchers and other healthcare professionals.
   
• Additionally, benchtop CD spectrometers are generally more stable and reproducible compared to portable instruments, making them suitable for long-term studies and routine laboratory use.
   

The circular dichroism spectrometers market by end-use is categorized into pharmaceutical industry, government and private research organizations, and contract research organizations (CROs). The pharmaceutical industry segment dominates the market with a revenue of around USD 16.6 million in 2023.
 

• Increased investment in pharmaceutical R&D leads to the development of more drug candidates, particularly biologics, which require extensive structural characterization. CD spectrometers play a crucial role in this process by providing detailed information about the secondary and tertiary structures of biomolecules, aiding in the selection and optimization of drug candidates. This increasing investment by pharmaceutical industries is anticipating propelling the segment landscape.   
   
• Moreover, the pharmaceutical industry has seen a significant increase in the development and use of biologics, including monoclonal antibodies, recombinant proteins, and nucleic acid-based therapeutics. CD spectrometers play a vital role in characterizing the structure and stability of biologics, ensuring their efficacy, safety, and regulatory compliance, anticipates their increased use pharma sector.

North America circular dichroism spectrometers market accounted for USD 21.4 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• North America, particularly the U.S., is home to numerous research institutions, academic centers, and pharmaceutical companies engaged in extensive research and development activities. The continuous investment in scientific research on CD spectrometers drives their demand in the region.
   
• Furthermore, academic research institutions and government agencies in North America provide substantial funding support for scientific research initiatives. This funding enables researchers to acquire state-of-the-art instrumentation, including CD spectrometers, to advance their studies in fields such as structural biology, protein chemistry, and molecular biophysics.